P. Douste-Blazy

发表

Effect of simvastatin on plasma lipids, apolipoproteins and lipoprotein particles in patients with primary hypercholesterolaemia

G. Luc, J. Fruchart, P. Drouin, 2004, European Journal of Clinical Pharmacology.

Human type II hyperlipoproteinemia enhances platelet-collagen adhesion in flowing nonanticoagulated blood.

J. Ferrières, B. Boneu, K. Sakariassen, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Fluorescence quenching by iodide ions of low density lipoproteins from normolipidemic and hypercholesterolemic type IIa subjects. Effect of low density lipoprotein-cholesterol and low density lipoprotein non-apolipoprotein-B.

R. Camare, P. Douste-Blazy, Q. Q. Dang, 1984, Chemistry and physics of lipids.

A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition.

G. Luc, E. Bruckert, R. Camare, 1992, Metabolism: clinical and experimental.

Comparison of cardiovascular risk factor levels in two French populations: Haute-Garonne (Toulouse) and Bas-Rhin (Strasbourg).

D. Arveiler, J. Ruidavets, R. Camare, 2009, Acta medica Scandinavica. Supplementum.

Effects of a low-energy diet associated with egg supplementation on plasma cholesterol and lipoprotein levels in normal subjects: results of a cross-over study

R. Camare, G. Corraze, D. Boulze, 1986, British Journal of Nutrition.

Autres pays, autres coeurs? Dietary patterns, risk factors and ischaemic heart disease in Belfast and Toulouse.

J. Ruidavets, C. Patterson, Z. Mathewson, 1995, QJM : monthly journal of the Association of Physicians.

Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.

J. Fruchart, J. Bard, H. Parra, 1990, Metabolism: clinical and experimental.

flowing nonanticoagulated blood Human type II hyperlipoproteinemia enhances platelet-collagen adhesion in

J. Ferrières, Y. Cadroy, P. Douste-Blazy, 2011 .

Lipoprotein particle analysis comparing simvastatin and fenofibrate.

G. Luc, E. Bruckert, R. Camare, 1991, Atherosclerosis.

Effect of Fenofibrate on Lipoprotein Particles Predictive of Coronary Atherosclerosis

J. Fruchart, P. Drouin, S. Marcovina, 1987 .

Characterization of Monoclonal Antibodies against HumanApolipoprotein E

Y. Marcel, R. Milne, P. Douste-Blazy, 2013 .

Characterization of monoclonal antibodies against human apolipoprotein E.

Y. Marcel, R. Milne, L. Retegui, 1981, The Journal of clinical investigation.

Heparin half‐life and sensitivity in normal subjects and in patients affected by deep vein thrombosis

B. Boneu, B. Eychenne, P. Sié, 1986, European journal of clinical investigation.

for coronary heart disease. The ECTIM Study A case-control study of lipoprotein particles in two populations at contrasting risk

D. Arveiler, P. Amouyel, D. Mcmaster, 2011 .

Screening for new mutations in the LDL receptor gene in seven French familial hypercholesterolemia families by the single strand conformation polymorphism method

C. Junien, B. Dastugue, C. Boileau, 1992, Human mutation.

Between-register and within-register variability in event-finding and rates in the MONICA-France Project.

D. Arveiler, J. Ruidavets, J. Richard, 1990, Revue d'epidemiologie et de sante publique.

Exercise-Induced Platelet Activation in Myocardial Infarction Survivors with Normal Coronary Arteriogram

P. Bernadet, J. Marco, B. Boneu, 1984, Thrombosis and Haemostasis.

Renal side effect of nifedipine

J. Pourrat, P. Douste-Blazy, 1984, Clinical cardiology.

A Few Dollars at a Time

D. Altman, P. Douste-Blazy, 2010 .

Skin apolipoprotein B values in normocholesterolaemic patients with coronary artery disease: a discriminatory test.

P. Bernadet, P. Valdiguie, H. Bouissou, 1985, British heart journal.

INFLUENCE OF AMIODARONE ON PLASMA AND URINE DIGOXIN CONCENTRATIONS

J. Montastruc, P. Bernadet, P. Auriol, 1984, The Lancet.

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND LITHIUM TREATMENT

B. Livarek, M. Rostin, P. Douste-Blazy, 1986, The Lancet.

A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.

A. Evans, D. Arveiler, G. Luc, 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

Is there any interaction between digoxin and enalapril?

M. Blanc, P. Douste-Blazy, J. Montastruc, 1986, British journal of clinical pharmacology.

Comparative Study of the Efficacy and Tolerability of Simvastatin and Pravastatin in Patients with Primary Hypercholesterolaemia

V. Ribeiro, L. Grossman, M. Seed, 1993 .

[Evaluation of mortality caused by ischemic heart disease in Haute-Garonne].

J. Ruidavets, P. Bernadet, J. Richard, 1990, Archives des maladies du coeur et des vaisseaux.

Increased Frequency of Apo E-ND phenotype and hyperapobeta-lipoproteinemia in normolipidemic subjects with xanthelasmas of the eyelids.

Y. Marcel, J. Davignon, P. Douste-Blazy, 1982, Annals of internal medicine.

Extended Haplotypes and Linkage Disequilibrium between I I Markers at the APOA IC 3-A 4 Gene Cluster on Chromosome

C. Junien, G., J., 2006 .

CANDIDATE GENE APPROACH TO TYPE IIa HYPERCHOLESTEROLAEMIA

C. Junien, P. Benlian, P. Douste-Blazy, 1989, The Lancet.

[Myocardial infarction in 3 French regions: comparison of incidence and mortality in 1985].

D. Arveiler, J. Ruidavets, J. Richard, 1988, Revue d'epidemiologie et de sante publique.

Abnormal in Vivo Platelet Activation During Exercise in Patients with Effort Kyocardial Infarction and Normal Coronary Arteriogram

P. Bernadet, J. Marco, B. Boneu, 1983 .